Haemonetics
Market cap
$5.608 B
$123.26 -3.26%
Close of 6 Nov 2026
As of 6 Nov 2026, Haemonetics (HAE) has a market capitalization of $5.61B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$1.33B
#1354 by revenue
Earnings
$97.3K
#2427 by earnings
Shares outstanding
45,537,511
Latest filing cover page
P/E ratio
57631.1
Cap ÷ net income
Medical/Dental Instruments, ranked by market cap
All 124 →- #14InsuletPODD$10.9B
- #15TeleflexTFX$6.46B
- #16HaemoneticsHAE$5.61B
- #17Merit Medical SystemsMMSI$5.36B
- #18MiniMed GroupMMED$5.14B
What if Haemonetics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Haemonetics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.